US pharma giant Pfizer announced that the issues at its sterile injectables plan in Kansas could be solved by the end of 2019 as constant supply could not be maintained after a warning letter from the FDA in 2017.
04 Feb 2019
Another good year for Kabi?
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Another good year for Kabi?
Fresenius SE & Co. KGaA (FRE:WBO) | 0 0 0.5% | Mkt Cap: 35,173m
- Published:
04 Feb 2019 -
Author:
Martin Schnee -
Pages:
2
US pharma giant Pfizer announced that the issues at its sterile injectables plan in Kansas could be solved by the end of 2019 as constant supply could not be maintained after a warning letter from the FDA in 2017.